Certified by Founder Lodge
Complement Therapeutics
United Kingdom - London
START UP
1 Disclosed Funding Rounds $78,929,000
0 Participating Investments
-
Founded date
2020
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Complement Therapeutics (CTx) is an early-stage biotechnology company focused on the research and development of novel therapeutics for complement-mediated diseases. The Company is a spinout
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| April, 18 ,2023 | Series A | $78,929,000 | |
| April, 19 ,2023 | Series A | Undisclosed Amount |
Cambridge Innovation Capital
Gimv
Forbion
Seroba Life Sciences
Hadean Venture
Panakes Partners
BGV (BioGeneration Ventures)
IDRx
CAMP4 Therapeutics
Delfi Diagnostics
xilis
Manifold Bio
PADO AI | $6,000,000 | (Mar 20, 2026)
Manifold Security | $8,000,000 | (Mar 19, 2026)
Beautiful.ai | $45,000,000 | (Mar 19, 2026)
Obin AI | $7,000,000 | (Mar 19, 2026)
SetSale | $2,000,000 | (Mar 19, 2026)